DEFA14A ·Filed Apr 10, 2026

RPRX

Royalty Pharma plc
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago SEC0001140361-26-014241
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine filing. No immediate action is required by traders. Monitor for the actual meeting date and any subsequent voting results.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
RPRX ▲ +20.52% at T+60d
NEUTRAL call ✓ call won +20.52% · α vs SPY +11.60% · entry $48.43 → $58.37
Entry anchored
Apr 10, 03:59 PM ET
via exchange tick
T+1d
+0.81%
call +0.81% · α -0.40%
$48.82
settled 6mo ago
T+5d
+1.80%
call +1.80% · α -1.50%
$49.30
settled 6mo ago
T+20d
+6.65%
call +6.65% · α -1.08%
$51.65
settled 5mo ago
T+60d
+20.52%
call +20.52% · α +11.60%
$58.37
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Royalty Pharma plc has filed a definitive proxy statement (DEFA14A) for an upcoming shareholder meeting. The filing is routine and does not indicate any activist campaign or contested vote. It is a standard annual disclosure required by the SEC.

Key Facts

  • Company: Royalty Pharma plc (RPRX)
  • Filing Type: DEFA14A (Definitive Proxy Statement)
  • Purpose: Routine annual shareholder meeting
  • No activist involvement or contested votes
  • No new financial information disclosed

Financial Impact

No immediate financial impact

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001140361-26-014241
Document: 0001140361-26-014241-index-headers.html0001140361-26-014241
Document: 0001140361-26-014241-index.html0001140361-26-014241
Document: 0001140361-26-014241.txt0001140361-26-014241
18 reports for RPRX
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +15.20%May 6, 2026
Filters
Rows
Reports for RPRX — sortable, filterable
TypeNow
Sep 4, 2026
27d ago
Press Release
BEARISH ★ 5/10
$60.59 $58.47▲ +3.50%▲ +2.38%$57.16 (+5.66%)
Aug 19, 2026
6w ago
Insider Cluster
NEUTRAL ★ 3/10
$61.73 $61.80▲ +0.11%▲ +0.50%$57.16 (−7.40%)
Aug 12, 2026
7w ago
144
NEUTRAL ★ 3/10
$58.56 $60.58▲ +3.45%▲ +5.41%$57.16 (−2.39%)
Aug 5, 2026
8w ago
8-K
BULLISH ★ 6/10
$57.75 $59.22▲ +2.55%▲ +2.19%$57.16 (−1.02%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$57.77 $57.96▲ +0.33%▼ −0.60%$57.16 (−1.06%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$57.77 $57.96▲ +0.33%▼ −0.60%$57.16 (−1.06%)
May 28, 2026
18w ago
Insider Cluster
NEUTRAL ★ 4/10
$55.76 $55.87▲ +0.20%▲ +2.72%$57.16 (+2.51%)
May 28, 2026
18w ago
8-K
NEUTRAL ★ 4/10
$55.76 $54.97▼ −1.42%▼ −1.12%$57.16 (+2.51%)
May 22, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$54.50 $55.18▲ +1.25%▼ −0.41%$57.16 (+4.88%)
May 15, 2026
19w ago
Insider Cluster
NEUTRAL ★ 3/10
$52.07 $53.86▲ +3.44%▲ +1.82%$57.16 (+9.78%)
Showing 10 of 18

US Market Status

Market Closed — Opens Mon (65h 5m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access